People taking GLP1 medications, especially semaglutide (Ozempic, Wegovy), at some point, will start to notice a change thats as frustrating as it is unexpected: a loss of facial fullness, and a new layer of loose, sagging skin may appear
The use and popularity of semaglutide are expected to increase significantly moving forward due to its efficacy and safety profile
Researchers from Oxford University analyzed 37 studies that examined what happened when people stopped taking weight loss drugs
While some subcutaneous medications (particularly insulin) may show more pronounced site-related absorption differences, this is not a significant concern with GLP-1 receptor agonists as used in clinical practice
Committing to hormone replacement therapy is a serious decision
You have a broader suite of chemicals being picked up across the country, he said